» Articles » PMID: 21717434

The Association of Robotic Surgical Technology and Hospital Prostatectomy Volumes: Increasing Market Share Through the Adoption of Technology

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2011 Jul 1
PMID 21717434
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite limited and conflicting evidence for the efficacy of newly developed robotic technology for laparoscopic prostatectomy, this technology is spreading rapidly. Because the newer technology is more costly, reasons for this rapid adoption are unclear. The authors of this report sought to determine whether hospital acquisition of robotic technology was associated with volume of prostate cancer surgery.

Methods: The inpatient dataset of claims records from 2002 to 2008 and the acquisition dates of robotic technology were used to examine the rates of prostatectomy in Wisconsin hospitals. In analyses that accounted for hospital and referral region characteristics, changes in hospital prostatectomy volume were examined for their association with technology acquisition. Overall trends in the rate of prostatectomy also were examined over the study period.

Results: In total, 10,021 prostatectomies were performed in 52 hospitals in Wisconsin's 8 health referral regions during the study period. The mean quarterly prostatectomy volume in hospitals that did not acquire the technology was 4.5 in 2002 and 3.1 in 2007/2008. In contrast, the mean quarterly prostatectomy volume in hospitals that went on to acquire robotic technology was 16.5 in 2002 and 24.8 in 2007/2008. In adjusted models, the acquisition of a robot was associated with a 114% annual increase (95% confidence interval, 62%-177% annual increase) in hospital prostatectomy volume. The average Wisconsin hospital prostatectomy volume was unchanged during 2002 through 2006 but increased by 25.6% in 2007.

Conclusions: Robotic technology acquisition occurred rapidly in Wisconsin hospitals, and hospitals that acquired a robot had large increases in prostatectomy volume.

Citing Articles

Impact of Robotic Technologies on Prostate Cancer Patients' Choice for Radical Treatment.

Esperto F, Cacciatore L, Tedesco F, Testa A, Calle P, Ragusa A J Pers Med. 2023; 13(5).

PMID: 37240964 PMC: 10220733. DOI: 10.3390/jpm13050794.


Strategic and entrepreneurial abilities: Surviving the crisis across countries during the Covid-19 pandemic.

Chudzinski P, Cyfert S, Dyduch W, Koubaa S, Zastempowski M PLoS One. 2023; 18(5):e0285045.

PMID: 37134095 PMC: 10155951. DOI: 10.1371/journal.pone.0285045.


Medicare Accountable Care Organizations and the Adoption of New Surgical Technology.

Modi P, Kaufman S, Caram M, Ryan A, Shahinian V, Hollenbeck B J Am Coll Surg. 2020; 232(2):138-145.e2.

PMID: 33122038 PMC: 8030123. DOI: 10.1016/j.jamcollsurg.2020.10.016.


Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.

Kobayashi T, Kanao K, Araki M, Terada N, Kobayashi Y, Sawada A Int J Clin Oncol. 2017; 23(2):347-352.

PMID: 29127531 DOI: 10.1007/s10147-017-1203-1.


Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study.

Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J Lancet Oncol. 2017; 18(11):1445-1453.

PMID: 28986012 PMC: 5666166. DOI: 10.1016/S1470-2045(17)30572-7.